Kraig Biocraft Laboratories (KBLB) Equity Ratio (2010 - 2025)

Kraig Biocraft Laboratories has disclosed Equity Ratio across 16 years of filings, most recently posting 3.12 for Q4 2025.

• Equity Ratio for Q4 2025 came in at 3.12, up 42.41% year-over-year; the trailing twelve-month figure through Dec 2025 was 3.12 (up 42.41% YoY), and the FY2025 annual result was 3.12, up 42.41% from the prior year.
• Equity Ratio came in at 3.12 for Q4 2025 at Kraig Biocraft Laboratories, up from 3.38 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.69 in Q2 2022 to a low of 6.44 in Q1 2025.
• The 5-year median for Equity Ratio is 1.77 (2021), against an average of 2.55.
• Across the five-year window, Equity Ratio soared 88.6% in 2021 and plunged 206.67% in 2024, its largest moves.
• Kraig Biocraft Laboratories' Equity Ratio stood at 1.75 in 2021, then soared by 56.03% to 0.77 in 2022, then plunged by 129.12% to 1.77 in 2023, then slumped by 206.67% to 5.41 in 2024, then surged by 42.41% to 3.12 in 2025.
• The last three Equity Ratio figures came in at 3.12 (Q4 2025), 3.38 (Q3 2025), and 5.32 (Q2 2025), per Business Quant data.